Private Equity
Hanover, Maryland-based Cognate BioServices, a contract development and manufacturing organization in the global cellular therapies industry, has raised an undisclosed amount of funding. The investors included Tennenbaum Capital Partners LLC, Medivate Partners and an unnamed sovereign wealth fund. Also, Cognate has completed a management buyout.
3 min read · 20 February 2018
Brentwood Capital Advisors, a healthcare and tech-focused investment bank, has named John Kibler as managing director. Kibler is a former partner and managing director at William Blair.
2 min read · 20 February 2018
Insight Venture Partners has made a "significant" investment in Pompano Beach, Florida-based CentralReach, a provider of electronic health record and practice management software for clinics focused on applied behavioral analysis and speech therapy. No financial terms were disclosed.
3 min read · 16 February 2018
2 min read · 15 February 2018
Locus Point Capital has raised almost $96 million for its new private credit fund, according to an SEC filing. No target was listed on the document. Red Bank, New Jersey-based Locus Point Capital is a specialty finance company for small to mid-sized healthcare providers.
1 min read · 15 February 2018
TPG Capital has closed its previously announced take-private buyout of Exactech for $49.25 per share or about $737 million. Starting February 15, 2018, Exactech will no longer trade on the NASDAQ. Based in Gainesville, Florida, Exactech is a developer of orthopaedic implant devices and surgical instrumentation for extremities and large joints.
3 min read · 15 February 2018
New York-based healthcare-focused private equity firm MTS Health Investors has rebranded as WindRose Health Investors LLC. WindRose currently manages over $700 million in capital.
2 min read · 15 February 2018
Denmark and Cary, North Carolina-based Veloxis Pharmaceuticals, which is focused on treating transplant patients, has secured $60 million in debt funding from Athyrium Capital Management. The capital will be used to refinance outstanding debt, accelerate the growth of Envarsus XR in the U.S. and for working capital.
3 min read · 14 February 2018
Charles River Laboratories International has agreed to acquire MPI Research, a provider of testing services for biopharmaceutical and medical devices, for about $800 million in cash. Morgan Stanley is serving as financial adviser to Charles River on the transaction while Jefferies LLC and SunTrust Robinson Humphrey Inc are doing likewise for MPI. Charles River is backed by Avista Capital Partners.
4 min read · 14 February 2018
3 min read · 13 February 2018
